Gordon Cook
University of Leeds
H-index: 81
Europe-United Kingdom
Top articles of Gordon Cook
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Determinants of durable humoral and T cell immunity in myeloma patients following COVID‐19 vaccination | European Journal of Haematology | Clement Twumasi Sally Moore Ross Sadler Sally Jeans Sherin Varghese | 2024/4 |
Impact of minimal residual disease (MRD) in salvage autologous stem cell transplantation for relapsed myeloma: results from the NCRI Myeloma X (intensive) trial | Bone Marrow Transplantation | Ruth M de Tute Gordon Cook David A Cairns Julia M Brown Jamie Cavenagh | 2024/1/9 |
Genomic Classification and Individualized Prognosis in Multiple Myeloma | Journal of Clinical Oncology | Francesco Maura Arjun Raj Rajanna Bachisio Ziccheddu Alexandra M Poos Andriy Derkach | 2024/1/9 |
Radiocarbon Dates from samples funded by English Heritage between 2003 and 2006 | Peter Marshall Alex Bayliss Christopher Bronk Ramsey Gordon Cook Gerry McCormac | 2024/4/28 | |
Immune responses and clinical outcomes after COVID-19 vaccination in patients with liver disease and liver transplant recipients | Journal of Hepatology | Sam M Murray Elisa Pose Melanie Wittner Maria-Carlota Londoño Golda Schaub | 2024/1/1 |
Poems Syndrome and Disease Produced by Other Monoclonal IGs | Gordon Cook Montserrat Rovira | 2024/4/11 | |
Development and internal validation of a risk prediction model to identify myeloma based on routine blood tests: a case-control study | Annals of Epidemiology | Sorochi Iloanusi Ismaeel Yunusa Osaro Mgbere Susan M Abughosh Hua Chen | 2023/11/1 |
Individualized risk stratification in newly diagnosed multiple myeloma | Cancer Research | Arjun Raj Rajanna Francesco Maura Andriy Derkach Bachisio Ziccheddu Niels Weinhold | 2023/4/4 |
P-357 Individualized risk in newly diagnosed multiple myeloma | Clinical Lymphoma Myeloma and Leukemia | Francesco Maura Arjun Rajanna Bachisio Ziccheddu Andriy Derkach Alexandra Poos | 2023/9/1 |
Health-Related Quality of Life (HRQoL) in Fit, Unfit and Frail Patients Enrolled in Fitness (UK-MRA Myeloma XIV): A Cross Sectional Study | Blood | Orla McCourt David Allan Cairns Sally Moore Christopher Parrish Charlotte Pawlyn | 2023/11/28 |
The Impact of Epstein-Barr Virus Infection on Second Cancer Development in Newly Diagnosed Myeloma Patients Treated with Lenalidomide in the UK NCRI Myeloma XI Trial | Blood | Molly Reed David Allan Cairns Charlotte Pawlyn Faith E Davies Rachel Sigsworth | 2023/11/28 |
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease | Nature Medicine | Eleanor Barnes Carl S Goodyear Michelle Willicombe Charlotte Gaskell Stefan Siebert | 2023/7 |
What can we do about patients presenting with myeloma and severe renal failure? Observations from the UK MERIT plasma exchange trial | EJHaem | Judith Behrens Gill Gaskin Neil Iggo Jonathan Barratt Jane Tighe | 2023/2 |
P-378 Longitudinal antibody and T-cell kinetics over four doses of COVID-19 vaccination and predictors of poor response in patients with multiple myeloma | Clinical Lymphoma Myeloma and Leukemia | Gaurav Agarwal Sally Moore Ross Sadler Sherin Varghese Alison Turner | 2023/9/1 |
The addition of vorinostat to lenalidomide maintenance for patients with newly diagnosed multiple myeloma of all ages: results from ‘Myeloma XI’, a multicentre, open‐label … | British Journal of Haematology | Matthew W Jenner Charlotte Pawlyn Faith E Davies Tom Menzies Anna Hockaday | 2023/4 |
High Success Rates Utilizing Local Standard of Care Cytogenetic Testing for Risk Stratified Frontline Therapy for Newly Diagnosed Multiple Myeloma: Experience from the Ukmra … | Blood | Dipal Mehta Laura Chiecchio Martin F Kaiser Sarah Gooding Kara-Louise Royle | 2023/11/28 |
Immune responses to COVID‐19 booster vaccinations in intensively anti‐CD38 antibody treated patients with ultra‐high‐risk multiple myeloma: results from the Myeloma UK (MUK … | British Journal of Haematology | Sian E Faustini Andrew Hall Sarah Brown Sadie Roberts Harriet Hill | 2023/6 |
RADAR Trial: MRD Response Adapted Trial for Newly Diagnosed Transplant Eligible Myeloma Patients | Blood | Karthik Ramasamy David Allan Cairns Kara-Louise Royle Robert Cicero Catherine Olivier | 2023/11/28 |
Switching to daratumumab SC from IV is safe and preferred by patients with multiple myeloma | Journal of Oncology Pharmacy Practice | Maria-Victoria Mateos Sophie Rigaudeau Supratik Basu Ivan Spicka Rik Schots | 2023/7 |
Delayed diagnosis resulting in increased disease burden in multiple myeloma: the legacy of the COVID-19 pandemic | Blood Cancer Journal | Jonathan Carmichael Frances Seymour Graham McIlroy Sarrah Tayabali Rosie Amerikanou | 2023/3/15 |
